4 reports

The APAC point of care diagnostics market is expected to grow from US$ 6,548.48 million in 2021 to US$ 15,641.78 million by 2028; it is estimated to grow at a CAGR of 13.2% from 2021 to 2028. The growing use of home-based poc devices is expected to surge the market.The increasing awareness about point of care testing is bringing the...

  • Point Of Care Testing
  • Diagnostics
  • Infectious Disease
  • APAC
  • Diabetes Prevalence
  • Cancer Incidence

The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where...

  • Point Of Care Testing
  • World
  • North America
  • United States
  • India
  • APAC
  • HIV AIDS Prevalence
  • Chronic Disease Prevalence

The global point of care diagnostics market is expected to reach US$ 70.89 Bn in 2027 from US$ 26.60 Bn in 2018. The market is estimated to grow with a CAGR of 11.8% from 2019-2027. The market for point of care diagnostics is expected to grow, owing to factors such as increasing incidences of infectious diseases, product launches and product...

  • Point Of Care Testing
  • World
  • Diabetes Prevalence
  • Cancer Incidence

Summary AnteoTech Ltd (AnteoTech) formerly Anteo Diagnostics Ltd is a leading medical technology company that develops and commercializes healthcare products.The company along with its subsidiaries is a provider of immunoassays, in-vitro diagnostics, and point of care (PoC) tests to entities involved in the life sciences,...

  • Infectious Disease
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Clinical Trial
  • Managed Care
  • United States
  • Medical Devices Sales